MedTrace Logo

Clinical Decision Support for Familial Hypercholesterolemia

NCT03989167 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460000

Last updated 2024-11-26

No results posted yet for this study

Summary

A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH thirty-six months after study initiation.

Conditions

  • Hypercholesterolemia, Familial
  • Clinical Decision Support

Interventions

OTHER

Clinical decision support

Computer-based support tool for identification of patients with high levels of total cholesterol or LDL-C, at high risk of being affected by FH.

Sponsors & Collaborators

  • University Hospital, Linkoeping

    lead OTHER

Principal Investigators

  • Lars O Karlsson, MD, PhD · Linkoping University. Linkoping University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-06
Primary Completion
2025-12-06
Completion
2025-12-06

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03989167 on ClinicalTrials.gov